Ventonix ( venetoclax 100 mg )

Ventonix (venetoclax 100 mg), a potent BCL-2 inhibitor prescribed for specific medical conditions. It is primarily used to effectively treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adult patients. Furthermore, Ventonix is recommended for adult individuals aged 75 years or older, or those with underlying health conditions that prevent them from undergoing intensive induction chemotherapy. In such cases, Ventonix is administered in combination with azacitidine, decitabine, or low-dose cytarabine to tackle newly diagnosed acute myeloid leukemia (AML).

Venetoclax price 100 mg in India

Venetoclax 100 mg price in India is only 6% of the cost of venetoclax 100 mg.

Venetoclax Dosage:

Venetoclax dosage can vary depending on the specific medical condition being treated. The dosage instructions should be provided by a healthcare professional and should be followed carefully. However, here is a general guideline for the recommended dosage of venetoclax in some common indications:

1. Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL):

   • Starting dose: 20 mg once daily.
   • Dose ramp-up: The dosage is gradually increased over a few weeks to reach the recommended daily maintenance dose.
   • Maintenance dose: Typically, the recommended maintenance dose is 400 mg once daily.
   • Duration of treatment: Treatment duration can vary based on individual response and tolerability.

2. Newly Diagnosed Acute Myeloid Leukemia (AML):

   • Venetoclax is used in combination with other medications such as azacitidine, decitabine, or low-dose cytarabine.
   • The specific dosage and treatment regimen should be determined by a healthcare professional based on the patient's age, overall health, and other factors.

It's important to note that the above dosage information is a general guideline and individualized dosing may differ. It's essential to consult with a healthcare professional who can provide accurate dosage instructions tailored to the patient's specific needs.

common side effects of venetoclax

Tumor lysis syndrome (TLS) is a significant concern when taking Venetoclax, as it can arise from the rapid breakdown of cancer cells. TLS has the potential to cause kidney failure, necessitating dialysis treatment, and can even be life-threatening. Prior to initiating Venetoclax, your healthcare provider will conduct tests to evaluate your risk of developing TLS. To mitigate this risk, you will receive additional medications before and during treatment with Venetoclax. Intravenous (IV) fluids may also be administered. Throughout your treatment, your healthcare provider will regularly monitor your blood for signs of TLS. It is crucial to attend all scheduled appointments for blood tests. If you experience any symptoms of TLS during Venetoclax treatment, promptly inform your healthcare provider. Symptoms to be aware of include fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual tiredness, and muscle or joint pain.

To help reduce the risk of TLS, it is important to consume an ample amount of water during Venetoclax treatment. Aim to drink 6 to 8 glasses (approximately 56 ounces in total) of water daily, starting two days before your first dose, on the day of your initial Venetoclax dose, and whenever your dosage is increased. Your healthcare provider may adjust your treatment plan by delaying, decreasing your dose, or discontinuing Venetoclax if you experience side effects. If you restart Venetoclax after a break of one week or longer, your healthcare provider may reassess your TLS risk and modify your dosage accordingly.